[DPHARMA] YoY Annualized Quarter Result on 30-Jun-2012 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
16-Aug-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
30-Jun-2012 [#2]
Profit Trend
QoQ- 1.19%
YoY- 5.59%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Revenue 203,814 162,236 151,652 140,824 136,658 129,554 123,456 8.71%
PBT 41,210 42,604 43,926 35,812 34,332 33,164 40,674 0.21%
Tax -11,576 -10,820 -9,150 -8,662 -8,620 -8,292 -9,754 2.89%
NP 29,634 31,784 34,776 27,150 25,712 24,872 30,920 -0.70%
-
NP to SH 29,634 31,784 34,776 27,150 25,712 24,872 30,920 -0.70%
-
Tax Rate 28.09% 25.40% 20.83% 24.19% 25.11% 25.00% 23.98% -
Total Cost 174,180 130,452 116,876 113,674 110,946 104,682 92,536 11.11%
-
Net Worth 190,284 179,045 187,340 162,400 154,105 140,182 136,003 5.75%
Dividend
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Div 11,193 11,103 11,101 9,716 9,718 12,491 166 101.68%
Div Payout % 37.77% 34.93% 31.92% 35.79% 37.80% 50.22% 0.54% -
Equity
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Net Worth 190,284 179,045 187,340 162,400 154,105 140,182 136,003 5.75%
NOSH 139,915 138,794 138,770 138,803 138,833 138,794 138,779 0.13%
Ratio Analysis
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
NP Margin 14.54% 19.59% 22.93% 19.28% 18.81% 19.20% 25.05% -
ROE 15.57% 17.75% 18.56% 16.72% 16.68% 17.74% 22.73% -
Per Share
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
RPS 145.67 116.89 109.28 101.46 98.43 93.34 88.96 8.56%
EPS 21.18 22.90 25.06 19.56 18.52 17.92 22.28 -0.83%
DPS 8.00 8.00 8.00 7.00 7.00 9.00 0.12 101.30%
NAPS 1.36 1.29 1.35 1.17 1.11 1.01 0.98 5.61%
Adjusted Per Share Value based on latest NOSH - 138,727
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
RPS 21.19 16.87 15.77 14.64 14.21 13.47 12.83 8.71%
EPS 3.08 3.30 3.62 2.82 2.67 2.59 3.21 -0.68%
DPS 1.16 1.15 1.15 1.01 1.01 1.30 0.02 96.68%
NAPS 0.1978 0.1861 0.1948 0.1688 0.1602 0.1457 0.1414 5.75%
Price Multiplier on Financial Quarter End Date
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Date 30/06/15 30/06/14 28/06/13 29/06/12 30/06/11 30/06/10 30/06/09 -
Price 2.65 2.97 2.38 2.23 2.34 2.45 2.13 -
P/RPS 1.82 2.54 2.18 2.20 2.38 2.62 2.39 -4.43%
P/EPS 12.51 12.97 9.50 11.40 12.63 13.67 9.56 4.58%
EY 7.99 7.71 10.53 8.77 7.91 7.31 10.46 -4.38%
DY 3.02 2.69 3.36 3.14 2.99 3.67 0.06 92.09%
P/NAPS 1.95 2.30 1.76 1.91 2.11 2.43 2.17 -1.76%
Price Multiplier on Announcement Date
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Date 25/08/15 26/08/14 28/08/13 16/08/12 18/08/11 24/08/10 26/08/09 -
Price 2.40 3.37 2.44 2.38 2.22 2.45 2.50 -
P/RPS 1.65 2.88 2.23 2.35 2.26 2.62 2.81 -8.48%
P/EPS 11.33 14.72 9.74 12.17 11.99 13.67 11.22 0.16%
EY 8.83 6.80 10.27 8.22 8.34 7.31 8.91 -0.15%
DY 3.33 2.37 3.28 2.94 3.15 3.67 0.05 101.26%
P/NAPS 1.76 2.61 1.81 2.03 2.00 2.43 2.55 -5.98%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment